Genetic Signatures Ltd (GSS) — Capital Reinvestment Ratio
Latest as of June 2022:
1.32x
Genetic Signatures Ltd (GSS) has a Capital Reinvestment Ratio of 1.32x as of June 2022, meaning it reinvests 1% of its operating cash flow (AU$1.93 Million) in capital expenditures (AU$2.55 Million). See Genetic Signatures Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.32x
Capex / Operating Cash Flow
Operating Cash Flow
AU$1.93 Million
AUD
Capital Expenditures
AU$2.55 Million
AUD
Data as of
Jun 2022
Most recent filing
Genetic Signatures Ltd Capital Reinvestment Ratio (2021–2022)
This chart tracks Genetic Signatures Ltd's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Genetic Signatures Ltd (2021–2022)
Year-by-year Capital Reinvestment Ratio for Genetic Signatures Ltd from 2021 to 2022. For live market cap and broader valuation context, see Genetic Signatures Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.30x | AU$9.81 Million | AU$2.99 Million | ▼ -74.3% |
| 2021 | 1.19x | AU$4.20 Million | AU$4.98 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow